I. Singh, A. Moser, H. Moser, and Y. Kishimoto, Adrenoleukodystrophy: Impaired Oxidation of Very Long Chain Fatty Acids in White Blood Cells, Cultured Skin Fibroblasts, and Amniocytes, Pediatric Research, vol.18, issue.3, pp.286-290, 1984.
DOI : 10.1203/00006450-198403000-00016

S. Kemp, F. Valianpour, P. Mooyer, W. Kulik, and R. Wanders, Method for Measurement of Peroxisomal Very-Long-Chain Fatty Acid ??-Oxidation in Human Skin Fibroblasts Using Stable-Isotope-Labeled Tetracosanoic Acid, Clinical Chemistry, vol.50, issue.10, pp.1824-1826, 2004.
DOI : 10.1373/clinchem.2004.038539

H. Moser, A. Moser, K. Frayer, W. Chen, J. Schulman et al., Adrenoleukodystrophy: Increased plasma content of saturated very long chain fatty acids, Neurology, vol.31, issue.10, pp.1241-1249, 1981.
DOI : 10.1212/WNL.31.10.1241

J. Mosser, A. Douar, C. Sarde, P. Kioschis, R. Feil et al., Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters, Nature, vol.361, issue.6414, pp.726-730, 1993.
DOI : 10.1038/361726a0

C. Van-roermund, W. Visser, L. Ijlst, A. Van-cruchten, M. Boek et al., The human peroxisomal ABC half transporter ALDP functions as a homodimer and accepts acyl-CoA esters, The FASEB Journal, vol.22, issue.12, pp.4201-4208, 2008.
DOI : 10.1096/fj.08-110866

R. Ofman, I. Dijkstra, C. Van-roermund, N. Burger, M. Turkenburg et al., The role of ELOVL1 in very long-chain fatty acid homeostasis and X-linked adrenoleukodystrophy, EMBO Molecular Medicine, vol.27, issue.3, pp.90-97, 2010.
DOI : 10.1002/emmm.201000061

L. Bezman and H. Moser, Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes, American Journal of Medical Genetics, vol.44, issue.5, pp.415-419, 1998.
DOI : 10.1002/(SICI)1096-8628(19980413)76:5<415::AID-AJMG9>3.0.CO;2-L

S. Kemp, A. Pujol, H. Waterham, B. Van-geel, C. Boehm et al., ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: Role in diagnosis and clinical correlations, Human Mutation, vol.57, issue.7, pp.499-515, 2001.
DOI : 10.1002/humu.1227

W. Hubbard, A. Moser, A. Liu, R. Jones, S. Steinberg et al., Newborn screening for X-linked adrenoleukodystrophy (X-ALD): Validation of a combined liquid chromatography???tandem mass spectrometric (LC???MS/MS) method, Molecular Genetics and Metabolism, vol.97, issue.3, pp.212-220, 2009.
DOI : 10.1016/j.ymgme.2009.03.010

C. Ceni, Über einen interessanten fall von gliomatöser Infiltration bei der Großhirnhemisphäre, Arch Psychiatr Nervenkr, vol.1899, issue.31, pp.809-819
DOI : 10.1007/bf02047161

W. Haberfeld and F. Spieler, Zur diffusen Hirn-R??ckenmarksklerose im Kindesalter, Deutsche Zeitschrift f??r Nervenheilkunde, vol.19, issue.Nr. 49, pp.436-463, 1910.
DOI : 10.1007/BF01629013

P. Schilder, Zur Kenntnis der sogenannten diffusen Sklerose. (??ber Encephalitis periaxialis diffusa.), Zeitschrift f??r die gesamte Neurologie und Psychiatrie, vol.36, issue.1, pp.1-60, 1912.
DOI : 10.1007/BF02901445

P. Schilder, Zur Frage der Encephalitis periaxialis diffusa (sogenannte diffuse Sklerose), Zeitschrift f??r die gesamte Neurologie und Psychiatrie, vol.26, issue.1, pp.359-376, 1913.
DOI : 10.1007/BF02895263

P. Schilder, Die Encephalitis periaxialis diffusa, Archiv f??r Psychiatrie und Nervenkrankheiten, vol.52, issue.1, pp.327-356, 1924.
DOI : 10.1007/BF01813381

D. Hoefnagel, S. Van-den-noort, and S. Ingbar, DIFFUSE CEREBRAL SCLEROSIS WITH ENDOCRINE ABNORMALITIES IN YOUNG MALES, Brain, vol.85, issue.3, pp.553-568, 1962.
DOI : 10.1093/brain/85.3.553

E. Siemerling and H. Creutzfeldt, Bronzekrankheit und sklerosierende Encephalomyelitis, Archiv f??r Psychiatrie und Nervenkrankheiten, vol.7, issue.69, pp.217-244, 1923.
DOI : 10.1007/BF01835678

M. Blaw, Melanodermic type leukodystrophy (adreno-leukodystrophy)In Handbook of Clinical Neurology, pp.128-133

C. Forsyth, M. Forbes, and J. Cumings, Adrenocortical Atrophy and Diffuse Cerebral Sclerosis, Archives of Disease in Childhood, vol.46, issue.247, pp.273-284, 1971.
DOI : 10.1136/adc.46.247.273

URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1647695/pdf

H. Schaumburg, E. Richardson, P. Johnson, R. Cohen, J. Powers et al., Schilder's Disease, Archives of Neurology, vol.27, issue.5, pp.458-460, 1972.
DOI : 10.1001/archneur.1972.00490170090014

M. Igarashi, H. Schaumburg, J. Powers, Y. Kishmoto, E. Kolodny et al., FATTY ACID ABNORMALITY IN ADRENOLEUKODYSTROPHY, Journal of Neurochemistry, vol.49, issue.4, pp.851-860, 1976.
DOI : 10.1111/j.1471-4159.1976.tb04461.x-i1

E. Von-neusser and J. Wiesel, Die Erkrankungen der Nebennieren, p.133, 2011.

H. , J. Nixon, and P. , Familial Addison's disease with spastic paraplegia, J Clin Endocrinol Metab, vol.15, pp.739-744, 1955.

R. Penman, Addison's Disease in Association with Spastic Paraplegia, BMJ, vol.1, issue.5170, p.402, 1960.
DOI : 10.1136/bmj.1.5170.402

H. Budka, E. Sluga, and W. Heiss, Spastic paraplegia associated with addison's disease: Adult variant of adreno-leukodystrophy, Journal of Neurology, vol.42, issue.3, pp.237-250, 1976.
DOI : 10.1007/BF00312873

J. Griffin, E. Goren, H. Schaumburg, W. Engel, and L. Loriaux, Adrenomyeloneuropathy: A probable variant of adrenoleukodystrophy I. Clinical and endocrinologic aspects, Neurology, vol.27, issue.12, pp.1107-1113, 1977.
DOI : 10.1212/WNL.27.12.1107

S. Laureti, G. Casucci, F. Santeusanio, G. Angeletti, P. Aubourg et al., X-linked adrenoleukodystrophy is a frequent cause of idiopathic Addison's disease in young adult male patients, J Clin Endocrinol Metab, vol.81, pp.470-474, 1996.

S. Hsieh and P. White, Presentation of Primary Adrenal Insufficiency in Childhood, The Journal of Clinical Endocrinology & Metabolism, vol.96, issue.6, pp.925-928, 2011.
DOI : 10.1210/jc.2011-0015

S. Laureti, A. Falorni, M. Volpato, G. Casucci, M. Picchio et al., Absence of Circulating Adrenal Autoantibodies in Adult-Onset X-Linked Adrenoleukodystrophy, Hormone and Metabolic Research, vol.28, issue.07, pp.319-322, 1996.
DOI : 10.1055/s-2007-979803

H. Moser, K. Smith, P. Watkins, J. Powers, A. Moser et al., X-linked adrenoleukodystrophy.I nThe Metabolic and Molecular Bases of Inherited Disease, pp.3257-3301, 2001.

B. Van-geel, J. Assies, R. Wanders, and P. Barth, X linked adrenoleukodystrophy: clinical presentation, diagnosis, and therapy, Journal of Neurology, Neurosurgery & Psychiatry, vol.63, issue.1, pp.4-14, 1997.
DOI : 10.1136/jnnp.63.1.4

J. Powers, Y. Liu, A. Moser, and H. Moser, The Inflammatory Myelinopathy of Adreno-Leukodystrophy, Journal of Neuropathology and Experimental Neurology, vol.51, issue.6, pp.630-643, 1992.
DOI : 10.1097/00005072-199211000-00007

M. Van-der-knaap and J. Valk, X-linked adrenoleukodystrophy.I nMagnetic Resonance of Myelination and Myelin Disorders, pp.176-190, 2005.

S. Wang, J. Wu, and Y. Cheng, Asymmetric Cerebral Lesion Pattern in X-linked Adrenoleukodystrophy, Journal of the Chinese Medical Association, vol.69, issue.8, pp.383-386, 2006.
DOI : 10.1016/S1726-4901(09)70277-1

D. Loes, S. Hite, H. Moser, A. Stillman, E. Shapiro et al., Adrenoleukodystrophy: a scoring method for brain MR observations, AJNR Am J Neuroradiol, vol.15, pp.1761-1766, 1994.

S. Garside, P. Rosebush, A. Levinson, and M. Mazurek, Late-Onset Adrenoleukodystrophy Associated With Long-Standing Psychiatric Symptoms, The Journal of Clinical Psychiatry, vol.60, issue.7, pp.460-468, 1999.
DOI : 10.4088/JCP.v60n0708

H. Moser, A. Mahmood, and G. Raymond, X-linked adrenoleukodystrophy, Nature Clinical Practice Neurology, vol.89, issue.3, pp.140-151, 2007.
DOI : 10.1038/ncpneuro0421

B. Van-geel, J. Koelman, P. Barth, and B. Ongerboer-de-visser, Peripheral nerve abnormalities in adrenomyeloneuropathy: A clinical and electrodiagnostic study, Neurology, vol.46, issue.1, pp.112-118, 1996.
DOI : 10.1212/WNL.46.1.112

M. Engelen, A. Van-der-kooi, S. Kemp, R. Wanders, E. Sistermans et al., X-linked adrenomyeloneuropathy due to a novel missense mutation in the ABCD1 start codon presenting as demyelinating neuropathy, Journal of the Peripheral Nervous System, vol.18, issue.Suppl 1, pp.353-355, 2011.
DOI : 10.1111/j.1529-8027.2011.00367.x

E. Kararizou, N. Karandreas, P. Davaki, R. Davou, and D. Vassilopoulos, Polyneuropathies in teenagers: A clinicopathological study of 45 cases, Neuromuscular Disorders, vol.16, issue.5, pp.304-307, 2006.
DOI : 10.1016/j.nmd.2006.03.001

J. Powers, D. Deciero, M. Ito, A. Moser, and H. Moser, Adrenomyeloneuropathy, Journal of Neuropathology & Experimental Neurology, vol.59, issue.2, pp.89-102, 2000.
DOI : 10.1093/jnen/59.2.89

P. Dubey, A. Fatemi, H. Huang, L. Nagae-poetscher, S. Wakana et al., Diffusion tensor-based imaging reveals occult abnormalities in adrenomyeloneuropathy, Annals of Neurology, vol.64, issue.5, pp.758-766, 2005.
DOI : 10.1002/ana.20643

A. Fatemi, S. Smith, P. Dubey, K. Zackowski, A. Bastian et al., Magnetization transfer MRI demonstrates spinal cord abnormalities in adrenomyeloneuropathy, Neurology, vol.64, issue.10, pp.1739-1745, 2005.
DOI : 10.1212/01.WNL.0000164458.02141.06

S. Smith, X. Golay, A. Fatemi, A. Mahmood, G. Raymond et al., Quantitative magnetization transfer characteristics of the human cervical spinal cord in vivo: Application to Adrenomyeloneuropathy, Magnetic Resonance in Medicine, vol.254, issue.1, pp.22-27, 2009.
DOI : 10.1002/mrm.21827

B. Van-geel, L. Bezman, D. Loes, H. Moser, and G. Raymond, Evolution of phenotypes in adult male patients with X-linked adrenoleukodystrophy, Annals of Neurology, vol.78, issue.2
DOI : 10.1002/1531-8249(20010201)49:2<186::AID-ANA38>3.0.CO;2-R

H. Moser, A. Moser, S. Naidu, and A. Bergin, Clinical Aspects of Adrenoleukodystrophy and Adrenomyeloneuropathy, Developmental Neuroscience, vol.13, issue.4-5, pp.254-261, 1991.
DOI : 10.1159/000112170

J. Assies, L. Gooren, G. Van, and P. Barth, Signs of testicular insufficiency in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy: a retrospective study, International Journal of Andrology, vol.20, issue.5, pp.315-321, 1997.
DOI : 10.1046/j.1365-2605.1997.00066.x

O. Neill, B. Moser, H. Saxena, K. Marmion, and L. , Adrenoleukodystrophy: Clinical and biochemical manifestations in carriers, Neurology, vol.34, issue.6, pp.798-801, 1984.
DOI : 10.1212/WNL.34.6.798

S. El-deiry, S. Naidu, L. Blevins, and P. Ladenson, Assessment of Adrenal Function in Women Heterozygous for Adrenoleukodystrophy, Journal of Clinical Endocrinology & Metabolism, vol.82, issue.3, pp.856-860, 1997.
DOI : 10.1210/jc.82.3.856

S. Naidu, C. Washington, S. Thirumalai, K. Smith, H. Moser et al., X-chromosome inactivation in symptomatic heterozygotes of X-linked adrenoleukodystrophy, Ann Neurol, vol.42, p.498, 1997.

E. Maier, S. Kammerer, A. Muntau, M. Wichers, A. Braun et al., Symptoms in carriers of adrenoleukodystrophy relate to skewed X inactivation, Annals of Neurology, vol.248, issue.5, pp.683-688, 2002.
DOI : 10.1002/ana.10376

E. Salsano, S. Tabano, S. Sirchia, P. Colapietro, B. Castellotti et al., Preferential expression of mutant ABCD1 allele is common in adrenoleukodystrophy female carriers but unrelated to clinical symptoms, Orphanet Journal of Rare Diseases, vol.7, issue.1, p.10, 2012.
DOI : 10.1056/NEJM198301273080401

J. Berger, B. Molzer, I. Fae, and H. Bernheimer, X-Linked Adrenoleukodystrophy (ALD): A Novel Mutation of the ALD Gene in 6 Members of a Family Presenting with 5 Different Phenotypes, Biochemical and Biophysical Research Communications, vol.205, issue.3, pp.1638-1643, 1994.
DOI : 10.1006/bbrc.1994.2855

S. Kemp, M. Ligtenberg, B. Van-geel, P. Barth, R. Wolterman et al., Identification of a Two Base Pair Deletion in Five Unrelated Families with Adrenoleukodystrophy: A Possible Hot Spot for Mutations, Biochemical and Biophysical Research Communications, vol.202, issue.2, pp.647-653, 1994.
DOI : 10.1006/bbrc.1994.1979

N. Maestri and T. Beaty, Predictions of a 2-locus model for disease heterogeneity: Application to adrenoleukodystrophy, American Journal of Medical Genetics, vol.305, issue.5, pp.576-582, 1992.
DOI : 10.1002/ajmg.1320440509

K. Smith, G. Sack, T. Beaty, A. Bergin, S. Naidu et al., A genetic basis for the multiple phenotypes of X-linked adrenoleukodystrophy, Am J Hum Genet, vol.49, p.165, 1991.

S. Kemp, F. Theodoulou, and R. Wanders, Mammalian peroxisomal ABC transporters: from endogenous substrates to pathology and clinical significance, British Journal of Pharmacology, vol.32, issue.7, pp.1753-1766, 2011.
DOI : 10.1111/j.1476-5381.2011.01435.x

S. Kemp, F. Valianpour, S. Denis, R. Ofman, R. Sanders et al., Elongation of very long-chain fatty acids is enhanced in X-linked adrenoleukodystrophy, Molecular Genetics and Metabolism, vol.84, issue.2, pp.144-151, 2005.
DOI : 10.1016/j.ymgme.2004.09.015

J. Ho, H. Moser, Y. Kishimoto, and J. Hamilton, Interactions of a very long chain fatty acid with model membranes and serum albumin. Implications for the pathogenesis of adrenoleukodystrophy., Journal of Clinical Investigation, vol.96, issue.3, pp.1455-1463, 1995.
DOI : 10.1172/JCI118182

R. Knazek, W. Rizzo, J. Schulman, and J. Dave, Membrane microviscosity is increased in the erythrocytes of patients with adrenoleukodystrophy and adrenomyeloneuropathy., Journal of Clinical Investigation, vol.72, issue.1, pp.245-248, 1983.
DOI : 10.1172/JCI110963

R. Whitcomb, W. Linehan, and R. Knazek, Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro., Journal of Clinical Investigation, vol.81, issue.1, pp.185-188, 1988.
DOI : 10.1172/JCI113292

S. Hein, P. Schonfeld, S. Kahlert, and G. Reiser, Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture, Human Molecular Genetics, vol.17, issue.12, pp.1750-1761, 2008.
DOI : 10.1093/hmg/ddn066

S. Fourcade, J. Lopez-erauskin, J. Galino, C. Duval, A. Naudi et al., Early oxidative damage underlying neurodegeneration in X-adrenoleukodystrophy, Human Molecular Genetics, vol.17, issue.12, pp.1762-1773, 2008.
DOI : 10.1093/hmg/ddn085

J. Powers, Z. Pei, A. Heinzer, R. Deering, A. Moser et al., Adreno-leukodystrophy: Oxidative Stress of Mice and Men, Journal of Neuropathology and Experimental Neurology, vol.64, issue.12, pp.1067-1079, 2005.
DOI : 10.1097/01.jnen.0000190064.28559.a4

F. Eichler, J. Ren, M. Cossoy, A. Rietsch, S. Nagpal et al., Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?, Annals of Neurology, vol.147, issue.6, pp.729-742, 2008.
DOI : 10.1002/ana.21391

A. Pujol, C. Hindelang, N. Callizot, U. Bartsch, M. Schachner et al., Late onset neurological phenotype of the X-ALD gene inactivation in mice: a mouse model for adrenomyeloneuropathy, Human Molecular Genetics, vol.11, issue.5, pp.499-505, 2002.
DOI : 10.1093/hmg/11.5.499

A. Schluter, L. Espinosa, S. Fourcade, J. Galino, E. Lopez et al., Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy, Human Molecular Genetics, vol.21, issue.5, pp.1062-1077, 2012.
DOI : 10.1093/hmg/ddr536

Y. Wang, R. Busin, C. Reeves, L. Bezman, R. G. Toomer et al., X-linked adrenoleukodystrophy: ABCD1 de novo mutations and mosaicism, Molecular Genetics and Metabolism, vol.104, issue.1-2, pp.160-166, 2011.
DOI : 10.1016/j.ymgme.2011.05.016

S. Laureti, P. Aubourg, F. Calcinaro, F. Rocchiccioli, G. Casucci et al., Etiological Diagnosis of Primary Adrenal Insufficiency Using an Original Flowchart of Immune and Biochemical Markers, Journal of Clinical Endocrinology & Metabolism, vol.83, issue.9, pp.3163-3168, 1998.
DOI : 10.1210/jc.83.9.3163

S. Mukherjee, E. Newby, and J. Harvey, Adrenomyeloneuropathy in patients with `Addison's disease': genetic case analysis, Journal of the Royal Society of Medicine, vol.99, issue.5, pp.245-249, 2006.
DOI : 10.1258/jrsm.99.5.245

S. Wong, M. Boggild, T. Enevoldson, and N. Fletcher, Myelopathy but normal MRI: where next?, Practical Neurology, vol.8, issue.2, pp.90-102, 2008.
DOI : 10.1136/jnnp.2008.144121

C. Theda, R. Woody, S. Naidu, A. Moser, and H. Moser, Increased very long chain fatty acids in patients on a ketogenic diet: A cause of diagnostic confusion, The Journal of Pediatrics, vol.122, issue.5, pp.724-726, 1993.
DOI : 10.1016/S0022-3476(06)80013-2

C. Sevin, S. Ferdinandusse, H. Waterham, R. Wanders, and P. Aubourg, Autosomal recessive cerebellar ataxia caused by mutations in the PEX2 gene, Orphanet Journal of Rare Diseases, vol.6, issue.1, p.8, 2011.
DOI : 10.1186/1750-1172-6-8

URL : https://hal.archives-ouvertes.fr/inserm-00580953

L. Regal, M. Ebberink, N. Goemans, R. Wanders, M. De et al., Mutations in PEX10 are a cause of autosomal recessive ataxia, Annals of Neurology, vol.68, pp.259-263, 2010.
DOI : 10.1002/ana.22035

R. Wanders, S. Ferdinandusse, P. Brites, and S. Kemp, Peroxisomes, lipid metabolism and lipotoxicity, Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, vol.1801, issue.3, pp.272-280, 2010.
DOI : 10.1016/j.bbalip.2010.01.001

R. Wanders and H. Waterham, Biochemistry of Mammalian Peroxisomes Revisited, Annual Review of Biochemistry, vol.75, issue.1, pp.295-332, 2006.
DOI : 10.1146/annurev.biochem.74.082803.133329

R. Schiffmann and M. Van-der-knaap, Invited Article: An MRI-based approach to the diagnosis of white matter disorders, Neurology, vol.72, issue.8, pp.750-759, 2009.
DOI : 10.1212/01.wnl.0000343049.00540.c8

P. Barth, J. Gootjes, H. Bode, P. Vreken, C. Majoie et al., Late onset white matter disease in peroxisome biogenesis disorder, Neurology, vol.57, issue.11, pp.1949-1955, 2001.
DOI : 10.1212/WNL.57.11.1949

H. Rahil, J. Solassol, C. Philippe, G. Lefort, and P. Jonveaux, Rapid detection of common autosomal aneuploidies by quantitative fluorescent PCR on uncultured amniocytes, European Journal of Human Genetics, vol.10, issue.8, pp.462-466, 2002.
DOI : 10.1038/sj.ejhg.5200833

E. Shapiro, W. Krivit, L. Lockman, I. Jambaque, C. Peters et al., Long-term effect of bone-marrow transplantation for childhood-onset cerebral X-linked adrenoleukodystrophy, The Lancet, vol.356, issue.9231, pp.713-718, 2000.
DOI : 10.1016/S0140-6736(00)02629-5

W. Miller, S. Rothman, D. Nascene, T. Kivisto, T. Defor et al., Outcomes after allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report, Blood, vol.118, issue.7, pp.1971-1978, 2011.
DOI : 10.1182/blood-2011-01-329235

N. Cartier, S. Hacein-bey-abina, C. Bartholomae, G. Veres, M. Schmidt et al., Hematopoietic Stem Cell Gene Therapy with a Lentiviral Vector in X-Linked Adrenoleukodystrophy, Science, vol.326, issue.5954, pp.818-823, 2009.
DOI : 10.1126/science.1171242

P. Aubourg, C. Adamsbaum, M. Lavallard-rousseau, F. Rocchiccioli, N. Cartier et al., A Two-Year Trial of Oleic and Erucic Acids (???Lorenzo's Oil???) as Treatment for Adrenomyeloneuropathy, New England Journal of Medicine, vol.329, issue.11, pp.745-752, 1993.
DOI : 10.1056/NEJM199309093291101

B. Van-geel, J. Assies, E. Haverkort, J. Koelman, B. Verbeeten et al., Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil", Journal of Neurology, Neurosurgery & Psychiatry, vol.67, issue.3, pp.290-299, 1999.
DOI : 10.1136/jnnp.67.3.290

H. Moser, G. Raymond, S. Lu, L. Muenz, A. Moser et al., Follow-up of 89 Asymptomatic Patients With Adrenoleukodystrophy Treated With Lorenzo???s Oil, Archives of Neurology, vol.62, issue.7, pp.1073-1080, 2005.
DOI : 10.1001/archneur.62.7.1073

I. Singh, M. Khan, L. Key, and S. Pai, Lovastatin for X-Linked Adrenoleukodystrophy, New England Journal of Medicine, vol.339, issue.10, pp.702-703, 1998.
DOI : 10.1056/NEJM199809033391012

M. Engelen, R. Ofman, M. Dijkgraaf, M. Hijzen, L. Van-der-wardt et al., Lovastatin in X-Linked Adrenoleukodystrophy, New England Journal of Medicine, vol.362, issue.3, pp.276-277, 2010.
DOI : 10.1056/NEJMc0907735

J. Lopez-erauskin, S. Fourcade, J. Galino, M. Ruiz, A. Schluter et al., Antioxidants halt axonal degeneration in a mouse model of X-adrenoleukodystrophy, Annals of Neurology, vol.256, issue.suppl 1, pp.84-92, 2011.
DOI : 10.1002/ana.22363